Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis.
Resource Type
Report
Authors
Stauffer VL; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. vstauffer@lilly.com.; Oakes TM; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA.; Rettiganti M; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA.; Day KA; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA.; Camporeale A; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA.
Source
Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE